cancer weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of cancer weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Gene silencing molecules inhibit tumor growth
December 14th, 2004
Bionomics Limited (BNO, BNOOA, BMICY) announced new data that show that gene-silencing molecules developed by the company inhibit tumor growth in a breast cancer model. The gene-silencing molecules target BNO69, one of Bionomics' proprietary drug targets. Bionomics' director of Cancer Research, Gabriel Kremmidiotis will present these results at two scientific symposia in the United States this week. Tumors that were treated with BNO69 gene-silencing molecules showed a reduction in size of over 75% compared to untreated tumors, in experiments conducted over 34 days. This result shows that BNO69 gene-silencing molecules have a...
Source: cancer weekly (2004-12-14)
|
